Peptide entry

LL-37

Research peptidePeptide

Quick facts

Category
Immune
Primary goal
Immune Support
Dose pattern
Daily
Treatment style
Fixed-dose or range
Status
Research peptide
Vial formats
2 mg

Evidence / context

Evidence: Limited. Immune-support context should stay targeted and short.

Available vial formats

LL-37

2 mg
Mix 3.0 mLConcentration 0.67 mg/mL

Dosing

  • Conservative 50-100 mcg once daily (7.5-15 units per injection)
  • Standard 100-200 mcg once daily (15-30 units per injection)
  • Aggressive 300 mcg once daily (45 units per injection) strict short cycle
Cycle length2-4 weeks (4+ off)
TimingMorning; avoid late if stimulating.Use a consistent daytime window during the short targeted block.

Reconstitution

  1. Swab vial tops with alcohol
  2. Draw 3.0 mL bacteriostatic water
  3. Inject slowly down vial wall (don't blast powder)
  4. Gently swirl - do not shake
  5. Rest 5-10 min to dissolve
  6. Refrigerate 2-8 C

Support / expected effects

Side effects / tolerability

Practical tips

Storage

Refrigerated: ~21-30 days.

Notes / compatibility

Compatibility

Rule: only mix water-based peptides sharing the same diluent and timing intent. If unsure, keep separate.

FAQ

What is LL-37 explored for?

Immune activation signaling. May support skin/mucosal defense in some protocols. Used in short targeted immune phases.

How is LL-37 reconstituted?

1) Swab vial tops with alcohol 2) Draw 3.0 mL bacteriostatic water 3) Inject slowly down vial wall (don't blast powder) 4) Gently swirl - do not shake 5) Rest 5-10 min to dissolve 6) Refrigerate 2-8 C

What is a typical cycle length for LL-37?

2-4 weeks (4+ off)

How are doses measured in syringe units here?

Units mean U-100 insulin-syringe gradations (1 mL = 100 units), not International Units. Use the calculator only when the vial concentration and injection volume are known.

Calculate the exact draw for LL-37Preloads the relevant vial format or fixed-ratio blend cycle.
Open calculator